首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1747288

按产品、应用、治疗适应症、最终用户和地区分類的血浆市场

Blood Plasma Market, By Product, By Application, By Therapeutic Indication, By End User, By Geography

出版日期: 2025年05月12日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球等离子市场规模预计为 3,880 万美元，预计到 2032 年将达到 7,950 万美元，2025 年至 2032 年的年复合成长率（CAGR）为 10.8%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	3880万美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	10.80%	2032年价值预测	7950万美元

全球血浆市场已成为医疗保健产业的重要组成部分，在治疗各种慢性和危及生命的疾病中发挥着至关重要的作用。血浆是血液的液体部分，含有用于开发治疗产品的必需蛋白质、凝血因子和抗体。该市场的重要性在于它能够满足日益增长的血浆衍生疗法的需求，这些疗法用于治疗免疫力缺乏、血友病、神经系统疾病等。随着这些疾病的盛行率持续上升，加上血浆采集和分离技术的进步，全球血浆市场有望显着成长。

市场动态：

全球血浆市场受多种因素驱动，例如慢性病盛行率上升、老年人口增长以及免疫球蛋白需求上升。血浆衍生疗法在治疗原发性免疫力缺乏和神经系统疾病等各种疾病的应用日益广泛，进一步推动了市场成长。此外，血浆采集和分离技术的进步提高了血浆衍生产品的效率和安全性，从而促进了市场成长。然而，市场也面临一些限制因素，例如血浆衍生疗法的高成本和血液感染疾病的风险。此外，对血浆产品采集、加工和分销的严格监管也可能为市场参与企业带来挑战。儘管存在这些市场限制因素，但新兴经济体对血浆衍生疗法的需求不断增长、新型血浆衍生产品的市场开发以及重组血浆蛋白的日益普及，正在为市场提供巨大的成长机会。此外，人们对血浆捐赠益处的认识不断提高以及全球血浆采集中心的扩张预计将在未来几年促进市场成长。

本研究的主要特点

本报告对全球等离子市场进行了详细分析，并提供了预测期（2025-2032）的市场规模（百万美元）和年复合成长率（CAGR%），假设 2024 年为基准年。
它还强调了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
它根据公司亮点、产品系列、主要亮点、财务业绩和策略等参数对全球等离子市场的主要企业进行了概述。
本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球血浆市场报告迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
相关人员将透过用于分析全球血浆市场的各种策略矩阵来做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 38.8 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	10.80%	2032 Value Projection:	USD 79.5 Mn

The global blood plasma market has emerged as a vital component of the healthcare industry, playing a crucial role in the treatment of various chronic and life-threatening diseases. Blood plasma, the liquid portion of blood, contains essential proteins, clotting factors, and antibodies that are used in the development of therapeutic products. The market's significance lies in its ability to address the growing demand for plasma-derived therapies, which are used to treat conditions such as immune deficiencies, hemophilia, and neurological disorders. As the prevalence of these diseases continues to rise, coupled with advancements in plasma collection and fractionation technologies, the global blood plasma market is poised for substantial growth.

Market Dynamics:

The global blood plasma market is driven by several factors, including the increasing prevalence of chronic diseases, the growing geriatric population, and the rising demand for immunoglobulins. The expanding applications of plasma-derived therapies in the treatment of various medical conditions, such as primary immunodeficiency disorders and neurological diseases, further fuel the market's growth. Additionally, advancements in plasma collection and fractionation technologies have improved the efficiency and safety of plasma-derived products, thereby boosting market growth. However, the market also faces certain restraints, such as the high cost of plasma-derived therapies and the risk of transmission of blood-borne infections. Moreover, stringent regulations governing the collection, processing, and distribution of blood plasma products can pose challenges to market participants. Despite these restraints, the market presents significant opportunities for growth, driven by the increasing demand for plasma-derived therapies in emerging economies, the development of novel plasma-derived products, and the rising adoption of recombinant plasma proteins. Furthermore, the growing awareness about the benefits of plasma donation and the expansion of plasma collection centers worldwide are expected to contribute to the market's growth in the coming years.

Key Features of the Study:

This report provides in-depth analysis of the global blood plasma market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global blood plasma market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include CSL Behring, Grifols, Takeda Pharmaceutical Company Limited, Octapharma, Kedrion Biopharma, Bio Products Laboratory (BPL), LFB Group, Sanquin Plasma Products, China Biologic Products Holdings, Inc, ADMA Biologics, GC Pharma, CSL Plasma, Emergent BioSolutions, Kamada, and Centurion Pharma
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global blood plasma market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood plasma market

Market Segmentation

Product Insights (Revenue, USD Mn, 2020 - 2032)
- Immunoglobulins
- Albumin
- Coagulation Factor Concentrates
- Factor VIII
- Factor IX
- Von Willebrand Factor
- Prothrombin Complex Concentrate
- Fibrinogen Concentrates
- Factor XIII
- Alpha-1 Antitrypsin
- Others
Application Insights (Revenue, USD Mn, 2020 - 2032)
- Hypogammaglobulinemia
- Immunodeficiency Diseases
- Hemophilia
- Von Willebrand's Disease
- Others
Therapeutic Indication Insights (Revenue, USD Mn, 2020 - 2032)
- Immunology
- Oncology
- Pulmonology
- Rheumatology
- Transplantation
- Neurology
- Hematology
- Others
Source Insights (Revenue, USD Mn, 2020 - 2032)
- Source Plasma
- Recovered Plasma
End User Insights (Revenue, USD Mn, 2020 - 2032)
- Hospitals & Clinics
- Research Laboratories
- Plasma Collection Centers
- Academic & Research Institutes
- Biopharmaceutical Companies
- Others
Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- CSL Behring
- Grifols
- Takeda Pharmaceutical Company Limited (formerly Shire)
- Octapharma
- Kedrion Biopharma
- Bio Products Laboratory (BPL)
- LFB Group
- Sanquin Plasma Products
- China Biologic Products Holdings, Inc
- ADMA Biologics
- GC Pharma
- CSL Plasma
- Emergent BioSolutions
- Kamada
- Centurion Pharma

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Blood Plasma Market, By Product
- Global Blood Plasma Market, By Application
- Global Blood Plasma Market, By Therapeutic Indication
- Global Blood Plasma Market, By Source
- Global Blood Plasma Market, By End User
- Global Blood Plasma Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Blood Plasma Market, By Product, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Immunoglobulins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Albumin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Coagulation Factor Concentrates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Factor VIII
Factor IX
Von Willebrand Factor
Prothrombin Complex Concentrate
Fibrinogen Concentrates
Factor XIII
Alpha-1 Antitrypsin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Blood Plasma Market, By Application, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
- Hypogammaglobulinemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Immunodeficiency Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Hemophilia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Von Willebrand's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Blood Plasma Market, By Therapeutic Indication, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Pulmonology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Rheumatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Transplantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Hematology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Blood Plasma Market, By Source, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Source Plasma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Recovered Plasma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Blood Plasma Market, By End User, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Plasma Collection Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Blood Plasma Market, By Region, 2020 - 2032, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

CSL Behring
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Grifols
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takeda Pharmaceutical Company Limited (formerly Shire)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Octapharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Kedrion Biopharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio Products Laboratory (BPL)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
LFB Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanquin Plasma Products
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
China Biologic Products Holdings, Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ADMA Biologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GC Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CSL Plasma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Emergent BioSolutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Kamada
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Centurion Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

按产品、应用、治疗适应症、最终用户和地区分類的血浆市场